Up a level |
Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke et al (show 17 more authors)
(2022)
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.
LIVER CANCER, 11 (4).
pp. 354-367.
Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke et al (show 18 more authors)
(2020)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Gut, 69 (8).
pp. 1492-1501.
Toyoda, Hienori, Tada, Toshifumi, Johnson, Philip J ORCID: 0000-0003-1404-0209, Izumi, Namiki, Kadoya, Masumi, Kaneko, Shuichi, Kokudo, Norihiro, Ku, Yonson, Kubo, Shoji, Kumada, Takashi et al (show 5 more authors)
(2017)
Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey.
JOURNAL OF GASTROENTEROLOGY, 52 (10).
pp. 1112-1121.